Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study

DM Jovanovic; M Sterclova; N Mogulkoc; K Lewandowska; V Muller; M Hajkova; Michael Studnicka; J Tekavec-Trkanjec; S Littnerova; M Vasakova

doi:10.1186/s12931-022-02033-6

Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study

DM Jovanovic, M Sterclova, N Mogulkoc, K Lewandowska, V Muller, M Hajkova, Michael Studnicka (Co-author), J Tekavec-Trkanjec, S Littnerova, M Vasakova

Department of Pneumology

Research output: Contribution to journal › Original Article › peer-review

18 Citations (Web of Science)

Original language	English
Pages (from-to)	135
Journal	RESPIRATORY RESEARCH
Volume	23
Issue number	1
DOIs	https://doi.org/10.1186/s12931-022-02033-6
Publication status	Published - 2022

Keywords

PREVALENCE
HYPERTENSION
PIRFENIDONE
MANAGEMENT
IMPACT

Access to Document

10.1186/s12931-022-02033-6

Cite this

@article{12d44436ba1249fda20aeff369729630,

title = "Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study",

keywords = "PREVALENCE, HYPERTENSION, PIRFENIDONE, MANAGEMENT, IMPACT",

author = "DM Jovanovic and M Sterclova and N Mogulkoc and K Lewandowska and V Muller and M Hajkova and Michael Studnicka and J Tekavec-Trkanjec and S Littnerova and M Vasakova",

note = "Studnicka: Department of Pneumology, Paracelsus Medical University, Salzburg, Austria",

year = "2022",

doi = "10.1186/s12931-022-02033-6",

language = "English",

volume = "23",

pages = "135",

journal = "RESPIRATORY RESEARCH",

issn = "1465-9921",

number = "1",

}

TY - JOUR

T1 - Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study

AU - Jovanovic, DM

AU - Sterclova, M

AU - Mogulkoc, N

AU - Lewandowska, K

AU - Muller, V

AU - Hajkova, M

AU - Studnicka, Michael

AU - Tekavec-Trkanjec, J

AU - Littnerova, S

AU - Vasakova, M

N1 - Studnicka: Department of Pneumology, Paracelsus Medical University, Salzburg, Austria

PY - 2022

Y1 - 2022

KW - PREVALENCE

KW - HYPERTENSION

KW - PIRFENIDONE

KW - MANAGEMENT

KW - IMPACT

U2 - 10.1186/s12931-022-02033-6

DO - 10.1186/s12931-022-02033-6

M3 - Original Article

C2 - 35624513

SN - 1465-9921

VL - 23

SP - 135

JO - RESPIRATORY RESEARCH

JF - RESPIRATORY RESEARCH

IS - 1

ER -